Arrow Mark Colorado Holdings LLC Olema Pharmaceuticals, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.61 $408,612 - $923,383	-200,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $1.16 Million - $2.81 Million	-298,217 Reduced 59.82%	200,300 $853,000
Q4 2021 Feb 14, 2022	SELL	$8.75 - $30.71 $977,173 - $3.43 Million	-111,677 Reduced 18.3%	498,517 $4.67 Million
Q3 2021 Nov 15, 2021	BUY	$22.96 - $30.13 $7.3 Million - $9.58 Million	317,871 Added 108.74%	610,194 $16.8 Million
Q2 2021 Aug 16, 2021	BUY	$21.15 - $36.14 $954,964 - $1.63 Million	45,152 Added 18.27%	292,323 $8.18 Million
Q1 2021 May 17, 2021	SELL	$27.81 - $53.64 $171,949 - $331,656	-6,183 Reduced 2.44%	247,171 $8.2 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $9.4 Million - $13.8 Million	253,354 New	253,354 $12.2 Million

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $360M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.